The Investor

The Most Extreme Return Concentration in VC History

UTIMCO's fund performance disclosures through November 2025 just dropped the most consequential LP transparency event in a decade. The headline numbers are staggering — but the fine print is what matters for your capital allocation.

Thrive Capital's 2022 Fund VIII posted 126% IRR, the highest single-vintage figure ever tracked in UTIMCO disclosures, driven by positions in OpenAI, Cursor, Ramp, and Base Power. Notable Capital's core 2023 fund swung from -48% to 96% IRR in a single year — almost certainly a single-company story (Anthropic). And Altimeter's Meghan Reynolds crystallized the macro picture: gross VC profit on just 3 LLM companies now equals ~70% of all VC profits from the prior decade.

Every single one of these headline IRR numbers is unrealized. These are private company mark-ups, not distributions. The most spectacular VC performance cycle in history is built entirely on paper.

The Concentration Problem You May Not See

Strip out OpenAI from Thrive's fund and Anthropic from Notable's fund, and these are good-not-great managers. Thrive's 2024 fund is slightly negative. Notable's pre-2023 funds lag peers. Sequoia's evergreen fund shows a respectable 14.78% IRR — underwhelming next to the AI leaders. HongShan (ex-Sequoia China) posted negative-to-flat IRRs across three consecutive vintages (2020-2022).

This creates an unprecedented structural challenge for LP portfolio construction. Traditional diversification across 8-12 VC managers assumed return drivers were distributed across hundreds of companies. Today, multiple GPs may hold overlapping positions in the same 3 LLM companies. Your "diversified" VC portfolio could be a concentrated bet on OpenAI and Anthropic marks — you just don't know it yet.

The IPO Sequencing Wild Card

Anthropic, OpenAI, and SpaceX are all planning imminent IPOs. If each offers just 15% of shares, the combined capital requirement would roughly match every dollar raised across all US IPOs in the past decade. The first to list captures disproportionate allocation before capital fatigue sets in. For LP exit planning, the sequencing of these three IPOs may be the single most consequential variable in tech investing this year.

The DPI Reckoning Timeline

In 24-36 months, the market will demand proof these IRRs convert to cash. GPs who can navigate IPOs, secondary sales, or structured liquidity for $100B+ private companies will cement their franchises. Those who can't will face brutal LP re-underwriting. The smart play right now: if you're selling secondary fund interests, the next 60-90 days represent peak narrative value. If you're buying, demand a significant discount to NAV that accounts for the paper-to-cash conversion risk on companies that have never traded publicly.

OpenAI's Internal War Footing

OpenAI's CEO of Applications Fidji Simo told staff they "cannot miss this moment because we are distracted by side quests" and is treating Anthropic's enterprise lead as a "code red." This isn't public posturing — it's an internal war footing leaked via the WSJ. OpenAI is killing side projects (Sora video, Atlas browser, e-commerce features, hardware, adult mode, ads) to refocus on two pillars: coding tools and business customers.

The Codex metric is the one to watch: quadrupling from ~500K to 2M+ weekly users since January shows organic developer demand exists. But consumer scale does not equal enterprise lock-in — the exact lesson OpenAI is learning the hard way.

Microsoft's $200B+ Distribution Advantage Is Failing

The most damning metric in today's intelligence: Microsoft Copilot has 6 million daily users versus ChatGPT's 440 million — a 73x gap. Enterprise add-on penetration sits at just 3% of Office subscribers. Microsoft's stock is down YTD. The largest software distribution moat in history is failing to convert on AI.

The response is dramatic: Nadella took direct oversight of Copilot engineering, former Snap exec Jacob Andreou was promoted to run the consolidated Copilot org, and Suleyman's scope narrowed to "Superintelligence efforts" only. Meanwhile, Microsoft reworked its OpenAI partnership to lift a ban on solo AGI development that was supposed to run through 2030. Perhaps most tellingly, Microsoft chose Anthropic's Claude — not OpenAI — to power Copilot Cowork, its new agentic product. That's Microsoft hedging against its own $13B+ bet.

When the company that invested $13B in OpenAI chooses a competitor's model for its flagship enterprise agent product, the market needs to reprice accordingly.

The Sovereign AI Third Way

Mistral launched Forge at GTC — a platform enabling enterprises and governments to train custom models from scratch on their own infrastructure, with zero data exposure. Launch partners include ASML, Ericsson, and the European Space Agency. CEO Arthur Mensch claims the company is tracking to surpass $1B ARR in 2026.

This is a genuinely new investable category. No US-based lab offers anything comparable for data-sovereign deployments. The EU AI Act and expanding European defense budgets create structural tailwinds. Mistral's forward-deployed scientist model mirrors Palantir circa 2015 — capital-intensive but defensible. If they execute, the $1B ARR is the floor, not the ceiling.

The Convergent Investment Thesis

The winner-take-all foundation model thesis is dead. Enterprise AI has fragmented into three competing strategies: Anthropic (developer-first B2B), OpenAI (consumer pivoting to enterprise, 12-18 months behind), and Mistral (sovereign on-prem). Application-layer companies benefit from this multi-model competition — but only if they've built switching costs. Any portfolio company single-threaded on one model provider is now carrying more risk.

The Phase Transition

JPMorgan-led banks halted a $5.3 billion debt deal for Qualtrics because investors refused to underwrite the paper amid fears of AI disruption. This is not an equity selloff or a valuation haircut — this is the credit market telling you that traditional software companies' cash flows are no longer considered durable enough to service leveraged debt.

When equity investors get nervous about AI, multiples compress gradually. When debt investors get nervous about AI, entire deal structures collapse overnight. Every PE-backed SaaS company approaching a refinancing window, leverage recap, or dividend recapitalization now faces a new question from lenders: "Can an AI agent replace your core value proposition in 18 months?"

The Budget Migration Is Structural, Not Cyclical

The conventional SaaS slowdown narrative — post-COVID normalization, rate sensitivity — is dangerously incomplete. AI foundation model providers absorbed $40 billion+ in enterprise budgets in approximately two years, and that spend didn't materialize from new budget. It was reallocated from existing software line items. One analysis attributes ~70% of the SaaS growth deceleration to this structural budget capture.

The market is applying a ruthless AI displacement discount that scales inversely with platform moat depth: large-cap SaaS (Salesforce, ServiceNow) is down ~25% YTD, while mid-cap SaaS (Asana) has been cut in half. The market's verdict is clear: platform-level SaaS survives AI disruption; feature-level SaaS gets eaten.

The Asana Take-Private Template

The dislocation is creating the best entry points in SaaS since 2022. Asana's math is remarkably clean:

CEO Dan Rogers dodged the take-private question on camera. Moskovitz has been increasing his holdings. The signal pattern is unmistakable. This template maps to an entire cohort of mid-cap SaaS: 40%+ insider ownership, positive FCF, $300M-$2B market cap, stock down 40%+ YTD.

The Terminal Value Question

If AI systematically erodes competitive moats, the S&P 500's ~20x FCF multiple on $58 trillion in market cap is indefensible. Repricing even to 12-14x destroys $15-20 trillion. Historical precedent: newspapers went from 12-15x EBITDA to 2-4x in a decade. The paradox: $300-500B/year in AI capex only pencils if the returns are durable — but AI is the very thing making returns short-lived. This reflexivity loop is the most important macro risk in the current cycle.